Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
Relationship Between Daily Symptom Fluctuations and Functional Impact in Fibromyalgia
Fibromyalgia is a chronic condition that commonly causes widespread pain, fatigue, and difficulty in daily activities. These symptoms may change from day to day, even when their average severity is similar.
This study aims to examine whether daily changes in pain and fatigue are related to functional impact in adults with fibromyalgia. Participants will complete clinical questionnaires at the first visit and record their pain and fatigue levels for seven days. Sleep quality and perceived control over symptoms will also be recorded. No treatment or additional medical procedure will be given as part of the study.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Fibromyalgia symptoms do not always remain at the same level. Pain and fatigue may increase or decrease between days and may also change between morning and evening. Clinical assessments usually focus on the average severity of these symptoms. However, patients with similar average pain or fatigue levels may have different levels of difficulty in daily life. This study will therefore examine whether symptom fluctuation provides additional information about functional impact beyond average symptom severity.
Adults diagnosed with fibromyalgia according to the 2016 American College of Rheumatology criteria will be included. At the initial visit, demographic and clinical information will be recorded. Functional impact will be assessed using the Fibromyalgia Impact Questionnaire. Anxiety and depression symptoms will be assessed using the Hospital Anxiety and Depression Scale, and symptoms related to central sensitization will be assessed using the Central Sensitization Inventory.
After the initial visit, participants will record pain and fatigue levels every morning and evening for seven days using 0-10 numerical rating scales. They will also record their sleep quality each morning and their perceived control over symptoms once daily. These records will be used to calculate average pain and fatigue levels, daily fluctuations in these symptoms, maximum symptom levels, and the degree to which pain and fatigue change together within each participant.
The main analysis will examine the relationship between pain and fatigue fluctuations and functional impact. It will also evaluate whether symptom fluctuation is related to functional impact after considering average pain and fatigue levels, age, sex, and disease duration. Additional analyses will examine the relationships of pain-fatigue synchrony, sleep quality, maximum symptom levels, and perceived symptom control with functional impact. The study is observational and is not designed to determine cause-and-effect relationships.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Taha Yasin YILDIRIM, M.D.
- Numero di telefono: +90 534 220 77 17
- Email: tyasinyildirim.ftr@gmail.com
Backup dei contatti dello studio
- Nome: Hatice Gözde Sümer, M.D.
- Numero di telefono: +90 532 157 72 99
- Email: gzdsmr@outlook.com
Luoghi di studio
-
-
-
Mardin, Turchia (Türkiye), 47100
- Reclutamento
- Mardin Training and Research Hospital
-
Contatto:
- Taha Yasin Yıldırım, M.D.
- Numero di telefono: +90 534 220 77 17
- Email: tyasinyildirim.ftr@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Diagnosis of fibromyalgia according to the 2016 American College of Rheumatology criteria
- Age between 18 and 65 years
- Ability to understand and complete the daily symptom records
- Ability and willingness to provide written informed consent
Exclusion Criteria:
- Active inflammatory rheumatic disease
- Major neurological disease
- Major change in fibromyalgia treatment within the previous three months
- Pregnancy, postpartum period, or breastfeeding
- Cognitive impairment or inability to provide informed consent
- Completion of less than 70% of the required daily symptom records
- Major change in fibromyalgia treatment during the seven-day monitoring period
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
|---|
|
Adults With Fibromyalgia
Adults aged 18-65 years who meet the 2016 American College of Rheumatology criteria for fibromyalgia will be included.
Participants will complete clinical questionnaires at the initial visit and record pain and fatigue levels for seven days.
Sleep quality and perceived symptom control will also be recorded.
No treatment or experimental intervention will be administered as part of the study.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Functional Impact Assessed by the Fibromyalgia Impact Questionnaire
Lasso di tempo: At the initial visit
|
Functional impact will be assessed using the Fibromyalgia Impact Questionnaire (FIQ).
The total score ranges from 0 to 100, with higher scores indicating greater impact of fibromyalgia.
The main analysis will examine whether within-person variability in pain and fatigue over seven days is associated with the FIQ score independently of average pain and fatigue levels.
|
At the initial visit
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Within-Person Association Between Pain and Fatigue
Lasso di tempo: During the 7-day monitoring period
|
Participants will rate pain and fatigue every morning and evening for seven days using 0-10 numerical rating scales.
The within-person correlation between paired pain and fatigue ratings will be calculated for each participant.
The relationship between this correlation and the FIQ total score will be examined.
|
During the 7-day monitoring period
|
|
Maximum Pain and Fatigue Levels
Lasso di tempo: During the 7-day monitoring period
|
The highest pain rating and the highest fatigue rating reported by each participant during the seven-day monitoring period will be identified separately.
Both are measured on scales from 0 to 10, with higher scores indicating greater symptom severity.
Their relationships with the FIQ total score will be examined.
|
During the 7-day monitoring period
|
|
Perceived Symptom Control
Lasso di tempo: During the 7-day monitoring period
|
Participants will rate their perceived control over their symptoms once daily for seven days using a scale from 0 to 10.
The relationship between perceived symptom control and the FIQ total score will be examined.
|
During the 7-day monitoring period
|
|
Sleep Quality
Lasso di tempo: During the 7-day monitoring period
|
Participants will rate the quality of the previous night's sleep each morning for seven days using a scale from 0 to 10.
The relationships of sleep quality with pain, fatigue, and the FIQ total score will be examined.
|
During the 7-day monitoring period
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Bartley EJ, Robinson ME, Staud R. Pain and Fatigue Variability Patterns Distinguish Subgroups of Fibromyalgia Patients. J Pain. 2018 Apr;19(4):372-381. doi: 10.1016/j.jpain.2017.11.014. Epub 2017 Dec 15.
- Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996 Dec;68(2-3):363-8. doi: 10.1016/s0304-3959(96)03226-5.
- Harris RE, Williams DA, McLean SA, Sen A, Hufford M, Gendreau RM, Gracely RH, Clauw DJ. Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 2005 Nov;52(11):3670-4. doi: 10.1002/art.21407.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- MTRH-PMR-TYY3
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .